subject: CHEBI:231614

object_name: PEComa


subject: CHEBI:231614

subject_name: Nivolumab

object_name: vulva carcinoma

tested_intervention: unsure


subject: CHEBI:231614

object_name: serous adenocarcinoma


subject: CHEBI:231614

object_name: serous cystadenocarcinoma


subject: CHEBI:231614

object_name: transitional cell carcinoma


subject: CHEBI:231614

object_name: seminoma


subject: CHEBI:231614

object_name: testicular germ cell tumor


subject: CHEBI:231614

object_name: testis seminoma


subject: CHEBI:231614

object_name: lung giant cell carcinoma


subject: CHEBI:231614

object_name: gallbladder carcinoma


subject: CHEBI:231614

object_name: acinar cell carcinoma


subject: CHEBI:231614

object_name: pediatric angiosarcoma


subject: CHEBI:231614

object_name: angiosarcoma


subject: CHEBI:231614

object_name: Adult Angiosarcoma


subject: CHEBI:231614

object_name: basal cell carcinoma


subject: CHEBI:231614

object_name: skin basal cell carcinoma


subject: CHEBI:231614

object_name: squamous cell carcinoma of the small intestine


subject: CHEBI:231614

object_name: ovarian transitional cell carcinoma


subject: CHEBI:231614

object_name: mucinous cystadenocarcinoma


subject: CHEBI:231614

object_name: Oropharyngeal lymphoepithelioma


subject: CHEBI:231614

object_name: major salivary gland carcinoma


subject: CHEBI:231614

object_name: small intestine adenocarcinoma


subject: CHEBI:231614

object_name: parathyroid gland carcinoma


subject: CHEBI:231614

object_name: pancreatic acinar cell carcinoma


subject: CHEBI:231614

object_name: Primary mucinous adenocarcinoma of ovary


subject: CHEBI:231614

object_name: ovarian mucinous adenocarcinoma


subject: CHEBI:231614

object_name: ureter squamous cell carcinoma


subject: CHEBI:231614

object_name: thyroid gland carcinoma


subject: CHEBI:231614

object_name: nasal cavity carcinoma


subject: CHEBI:231614

object_name: cervical adenocarcinoma


subject: CHEBI:231614

object_name: minimally invasive lung adenocarcinoma


subject: CHEBI:231614

object_name: malignant peripheral nerve sheath tumor


subject: CHEBI:231614

object_name: adult malignant schwannoma


subject: CHEBI:231614

object_name: childhood malignant schwannoma


subject: CHEBI:231614

object_name: undifferentiated carcinoma of esophagus


subject: CHEBI:231614

object_name: trachea carcinoma


subject: CHEBI:231614

object_name: Esophageal Neuroendocrine Carcinoma


subject: CHEBI:231614

object_name: mucinous adenocarcinoma of the appendix


subject: CHEBI:231614

object_name: adrenal gland pheochromocytoma


subject: CHEBI:231614

object_name: nasal cavity adenocarcinoma


subject: CHEBI:231614

object_name: ovarian squamous cell carcinoma


subject: CHEBI:231614

object_name: undifferentiated carcinoma of anal canal


subject: CHEBI:231614

object_name: oral cavity carcinoma


subject: CHEBI:231614

object_name: sex cord-stromal tumor


subject: CHEBI:231614

object_name: testicular sex cord-stromal neoplasm


subject: CHEBI:231614

object_name: metaplastic breast carcinoma


subject: CHEBI:231614

object_name: neuroendocrine carcinoma of anal canal


subject: CHEBI:231614

object_name: extrahepatic bile duct carcinoma


subject: CHEBI:231614

object_name: extramammary Paget disease


subject: CHEBI:231614

object_name: lung sarcomatoid carcinoma


subject: CHEBI:231614

object_name: Gastric neuroendocrine carcinoma


subject: CHEBI:231614

object_name: urethra squamous cell carcinoma


subject: CHEBI:231614

object_name: ovarian germ cell tumor


subject: CHEBI:231614

object_name: pediatric ovarian germ cell tumor


subject: CHEBI:231614

object_name: lung neuroendocrine neoplasm


subject: CHEBI:231614

object_name: lung carcinoid tumor


subject: CHEBI:231614

object_name: ovarian adenocarcinoma


subject: CHEBI:231614

object_name: scrotum squamous cell carcinoma


subject: CHEBI:231614

object_name: peritoneal mesothelioma


subject: CHEBI:231614

object_name: vaginal squamous cell carcinoma


subject: CHEBI:231614

object_name: endometrioid adenocarcinoma


subject: CHEBI:231614

object_name: squamous cell carcinoma of penis


subject: CHEBI:231614

object_name: undifferentiated carcinoma of stomach


subject: CHEBI:231614

object_name: Bartholin gland transitional cell carcinoma


subject: CHEBI:231614

object_name: Primary Peritoneal High Grade Serous Adenocarcinoma


subject: CHEBI:231614

object_name: pituitary adenocarcinoma


subject: CHEBI:231614

object_name: gastric squamous cell carcinoma


subject: CHEBI:231614

object_name: colorectal squamous cell carcinoma


subject: CHEBI:231614

object_name: vaginal adenocarcinoma


subject: CHEBI:231614

object_name: paranasal sinus carcinoma


subject: CHEBI:231614

object_name: testicular non-seminomatous germ cell tumor


subject: CHEBI:231614

object_name: spindle cell neoplasm


subject: CHEBI:231614

object_name: Malignant odontogenic tumor


subject: CHEBI:231614

object_name: Nasopharyngeal Low Grade Papillary Adenocarcinoma


subject: CHEBI:231614

object_name: fallopian tube transitional cell carcinoma


subject: CHEBI:231614

object_name: urethra adenocarcinoma


subject: CHEBI:231614

object_name: fibromatosis


subject: CHEBI:231614

object_name: desmoid tumor


subject: CHEBI:231614

object_name: pseudomyxoma peritonei


subject: CHEBI:231614

object_name: teratoma with malignant transformation


subject: CHEBI:231614

object_name: placental choriocarcinoma


subject: CHEBI:231614

object_name: carcinosarcoma


subject: CHEBI:231614

object_name: seminal vesicle adenocarcinoma


subject: CHEBI:231614

object_name: cervical clear cell adenocarcinoma


subject: CHEBI:231614

object_name: fallopian tube adenocarcinoma


subject: CHEBI:231614

object_name: apocrine sweat gland neoplasm


subject: CHEBI:231614

object_name: Myxofibroma


subject: CHEBI:231614

object_name: Malignant Solid Neoplasm


subject: CHEBI:231614

object_name: Rare Diseases


subject: UMLS:C2346820

object_name: endometrial transitional cell carcinoma


subject: UMLS:C2346820

object_name: transitional cell carcinoma of the corpus uteri


subject: UMLS:C2346820

object_name: ureter adenocarcinoma


subject: UMLS:C2346820

object_name: gestational trophoblastic neoplasm


subject: UMLS:C2346820

object_name: mucinous adenocarcinoma


subject: UMLS:C2346820

object_name: nasopharyngeal carcinoma

tested_intervention: yes


subject: UMLS:C2346820

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C2346820

object_name: undifferentiated carcinoma of nasopharynx


subject: UMLS:C2346820

object_name: cholangiocarcinoma


subject: UMLS:C2346820

object_name: bladder adenocarcinoma


subject: UMLS:C2346820

object_name: pancreatic endocrine carcinoma


subject: UMLS:C2346820

object_name: Neuroendocrine carcinoma of pancreas


subject: UMLS:C2346820

object_name: Plexosarcoma


subject: UMLS:C2346820

object_name: paraganglioma


subject: UMLS:C2346820

object_name: intrahepatic cholangiocarcinoma


subject: UMLS:C2346820

object_name: adrenal cortex carcinoma


subject: UMLS:C2346820

object_name: adenoid cystic carcinoma


subject: UMLS:C2346820

object_name: Intestinal Neuroendocrine Carcinoma


subject: UMLS:C2346820

object_name: chordoma


subject: UMLS:C2346820

object_name: PEComa


subject: UMLS:C2346820

object_name: vulva carcinoma


subject: UMLS:C2346820

object_name: serous adenocarcinoma


subject: UMLS:C2346820

object_name: serous cystadenocarcinoma


subject: UMLS:C2346820

object_name: transitional cell carcinoma


subject: UMLS:C2346820

object_name: seminoma


subject: UMLS:C2346820

object_name: testicular germ cell tumor


subject: UMLS:C2346820

object_name: testis seminoma


subject: UMLS:C2346820

object_name: lung giant cell carcinoma


subject: UMLS:C2346820

object_name: gallbladder carcinoma


subject: UMLS:C2346820

object_name: acinar cell carcinoma


subject: UMLS:C2346820

object_name: pediatric angiosarcoma


subject: UMLS:C2346820

object_name: angiosarcoma


subject: UMLS:C2346820

object_name: Adult Angiosarcoma


subject: UMLS:C2346820

object_name: basal cell carcinoma


subject: UMLS:C2346820

object_name: skin basal cell carcinoma


subject: UMLS:C2346820

object_name: squamous cell carcinoma of the small intestine


subject: UMLS:C2346820

object_name: ovarian transitional cell carcinoma


subject: UMLS:C2346820

object_name: mucinous cystadenocarcinoma


subject: UMLS:C2346820

object_name: Oropharyngeal lymphoepithelioma


subject: UMLS:C2346820

object_name: major salivary gland carcinoma


subject: UMLS:C2346820

object_name: small intestine adenocarcinoma


subject: UMLS:C2346820

object_name: parathyroid gland carcinoma


subject: UMLS:C2346820

object_name: pancreatic acinar cell carcinoma


subject: UMLS:C2346820

object_name: Primary mucinous adenocarcinoma of ovary


subject: UMLS:C2346820

object_name: ovarian mucinous adenocarcinoma


subject: UMLS:C2346820

object_name: ureter squamous cell carcinoma


subject: UMLS:C2346820

object_name: thyroid gland carcinoma


subject: UMLS:C2346820

object_name: nasal cavity carcinoma


subject: UMLS:C2346820

object_name: cervical adenocarcinoma


subject: UMLS:C2346820

object_name: minimally invasive lung adenocarcinoma


subject: UMLS:C2346820

object_name: malignant peripheral nerve sheath tumor


subject: UMLS:C2346820

object_name: adult malignant schwannoma


subject: UMLS:C2346820

object_name: childhood malignant schwannoma


subject: UMLS:C2346820

object_name: undifferentiated carcinoma of esophagus


subject: UMLS:C2346820

object_name: trachea carcinoma


subject: UMLS:C2346820

object_name: Esophageal Neuroendocrine Carcinoma


subject: UMLS:C2346820

object_name: mucinous adenocarcinoma of the appendix


subject: UMLS:C2346820

object_name: adrenal gland pheochromocytoma


subject: UMLS:C2346820

object_name: nasal cavity adenocarcinoma


subject: UMLS:C2346820

object_name: ovarian squamous cell carcinoma


subject: UMLS:C2346820

object_name: undifferentiated carcinoma of anal canal


subject: UMLS:C2346820

object_name: oral cavity carcinoma


subject: UMLS:C2346820

object_name: sex cord-stromal tumor


subject: UMLS:C2346820

object_name: testicular sex cord-stromal neoplasm


subject: UMLS:C2346820

object_name: metaplastic breast carcinoma


subject: UMLS:C2346820

object_name: neuroendocrine carcinoma of anal canal


subject: UMLS:C2346820

object_name: extrahepatic bile duct carcinoma


subject: UMLS:C2346820

object_name: extramammary Paget disease


subject: UMLS:C2346820

object_name: lung sarcomatoid carcinoma


subject: UMLS:C2346820

object_name: Gastric neuroendocrine carcinoma


subject: UMLS:C2346820

object_name: urethra squamous cell carcinoma


subject: UMLS:C2346820

object_name: ovarian germ cell tumor


subject: UMLS:C2346820

object_name: pediatric ovarian germ cell tumor


subject: UMLS:C2346820

object_name: lung neuroendocrine neoplasm


subject: UMLS:C2346820

object_name: lung carcinoid tumor


subject: UMLS:C2346820

object_name: ovarian adenocarcinoma


subject: UMLS:C2346820

object_name: scrotum squamous cell carcinoma


subject: UMLS:C2346820

object_name: peritoneal mesothelioma


subject: UMLS:C2346820

object_name: vaginal squamous cell carcinoma


subject: UMLS:C2346820

object_name: endometrioid adenocarcinoma


subject: UMLS:C2346820

object_name: squamous cell carcinoma of penis


subject: UMLS:C2346820

object_name: undifferentiated carcinoma of stomach


subject: UMLS:C2346820

object_name: Bartholin gland transitional cell carcinoma


subject: UMLS:C2346820

object_name: Primary Peritoneal High Grade Serous Adenocarcinoma


subject: UMLS:C2346820

object_name: pituitary adenocarcinoma


subject: UMLS:C2346820

object_name: gastric squamous cell carcinoma


subject: UMLS:C2346820

object_name: colorectal squamous cell carcinoma


subject: UMLS:C2346820

object_name: vaginal adenocarcinoma


subject: UMLS:C2346820

object_name: paranasal sinus carcinoma


subject: UMLS:C2346820

object_name: testicular non-seminomatous germ cell tumor


subject: UMLS:C2346820

object_name: spindle cell neoplasm


subject: UMLS:C2346820

object_name: Malignant odontogenic tumor


subject: UMLS:C2346820

object_name: Nasopharyngeal Low Grade Papillary Adenocarcinoma


subject: UMLS:C2346820

object_name: fallopian tube transitional cell carcinoma


subject: UMLS:C2346820

object_name: urethra adenocarcinoma


subject: UMLS:C2346820

object_name: fibromatosis


subject: UMLS:C2346820

object_name: desmoid tumor


subject: UMLS:C2346820

object_name: pseudomyxoma peritonei


subject: UMLS:C2346820

object_name: teratoma with malignant transformation


subject: UMLS:C2346820

object_name: placental choriocarcinoma


subject: UMLS:C2346820

object_name: carcinosarcoma


subject: UMLS:C2346820

object_name: seminal vesicle adenocarcinoma


subject: UMLS:C2346820

object_name: cervical clear cell adenocarcinoma


subject: UMLS:C2346820

object_name: fallopian tube adenocarcinoma


subject: UMLS:C2346820

object_name: apocrine sweat gland neoplasm


subject: UMLS:C2346820

object_name: Myxofibroma


subject: UMLS:C2346820

object_name: Malignant Solid Neoplasm


subject: UMLS:C2346820

object_name: Rare Diseases


subject: CHEBI:2569

subject_name: Alfentanil

object_name: Sedation


subject: CHEBI:2569

object_name: Sedated


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Kidney transplant failure and rejection


subject: UMLS:C0042210

subject_name: Vaccines

object_name: Hantavirosis


subject: UMLS:C0042210

object_name: hantavirus hemorrhagic fever with renal syndrome


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Dental Plaque


subject: DRUGBANK:DB16471

object_name: cancer


subject: DRUGBANK:DB16471

object_name: neoplasm


subject: DRUGBANK:DB16471


subject: DRUGBANK:DB16471

object_name: Liquid Tumor


subject: DRUGBANK:DB16471

object_name: leukemia


subject: DRUGBANK:DB16471

object_name: hematopoietic and lymphoid system neoplasm


subject: DRUGBANK:DB16471

object_name: Childhood Solid Neoplasm


subject: DRUGBANK:DB16471

object_name: Adult Solid Neoplasm


subject: DRUGBANK:DB16471

object_name: Solid Neoplasm


subject: DRUGBANK:DB16471

object_name: carcinoma


subject: UNII:P94L7H3TDK

object_name: Irritable bowel syndrome characterized by constipation


subject: UMLS:C3501342


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Refractory acute myeloid leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: Recurrent Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: BCLC Stage B Hepatocellular Carcinoma


subject: CHEBI:85994

object_name: BCLC Stage C Hepatocellular Carcinoma


subject: UMLS:C0353697

subject_name: carbidopa / levodopa

object_name: Parkinson disease


subject: GTOPDB:8988

subject_name: opicapone


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: head and neck squamous cell carcinoma


subject: UNII:6A901E312A

object_name: Squamous cell carcinoma of head and neck metastatic


subject: UNII:6A901E312A

object_name: stage IV cutaneous squamous cell carcinoma of the head and neck


subject: UMLS:C4744528

subject_name: Zirconium panitumumab Zr-89


subject: UMLS:C4744528


subject: UMLS:C4744528


subject: CHEBI:132922

object_name: Primary dysmenorrhea


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: pancreatic neoplasm


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: GTOPDB:13716

subject_name: disitamab vedotin

object_name: Biliary carcinoma


subject: UNII:RB3U3A1S27

subject_name: DISITAMAB VEDOTIN


subject: UMLS:C4329329


subject: CHEBI:4027

subject_name: Cyclophosphamide

object_name: adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: UMLS:C0733688


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: Plexosarcoma


subject: CHEBI:68647

subject_name: Regorafenib


subject: UMLS:C0079189

subject_name: cytokine

object_name: Neoplasm Metastasis


subject: UMLS:C0079189

object_name: breast neoplasm


subject: PUBCHEM.COMPOUND:64987

object_name: HIV infection


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:31536

subject_name: Emtricitabine


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: non-small cell lung carcinoma


subject: CHEBI:90943

subject_name: Osimertinib


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: Depressed mood


subject: PUBCHEM.COMPOUND:54675783

object_name: Cancer patients and suicide and depression


subject: PUBCHEM.COMPOUND:54675783

object_name: Depressed - symptom


subject: PUBCHEM.COMPOUND:54675783

object_name: Depression, CTCAE


subject: PUBCHEM.COMPOUND:54677977

subject_name: Teriflunomide

object_name: autoimmune thrombocytopenia


subject: PUBCHEM.COMPOUND:54677977

object_name: thrombocytopenia due to immune destruction


subject: PUBCHEM.COMPOUND:54677977

object_name: autoimmune thrombocytopenic purpura


subject: UNII:9RL37ZZ665

subject_name: Orantinib


subject: UNII:9RL37ZZ665

object_name: exocrine pancreatic carcinoma


subject: UNII:9RL37ZZ665

object_name: malignant pancreatic neoplasm


subject: UNII:9RL37ZZ665

object_name: colorectal cancer


subject: UNII:9RL37ZZ665

object_name: colorectal carcinoma


subject: UNII:9RL37ZZ665

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:9RL37ZZ665

object_name: prostate carcinoma


subject: UNII:9RL37ZZ665

object_name: prostate cancer


subject: UNII:9RL37ZZ665

object_name: Stomach cancer


subject: UNII:9RL37ZZ665

object_name: gastric cancer


subject: UNII:9RL37ZZ665

object_name: renal carcinoma


subject: UNII:9RL37ZZ665

object_name: kidney neoplasm


subject: UNII:9RL37ZZ665

object_name: kidney cancer


subject: UNII:9RL37ZZ665

object_name: Childhood Breast Carcinoma


subject: UNII:9RL37ZZ665

object_name: breast carcinoma


subject: UNII:9RL37ZZ665

object_name: breast cancer


subject: UNII:9RL37ZZ665

object_name: lung cancer


subject: UNII:9RL37ZZ665

object_name: lung neoplasm


subject: UNII:9RL37ZZ665

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:521403

subject_name: Norethandrolone

object_name: acute myeloid leukemia


subject: CHEBI:4445

subject_name: Desflurane

object_name: entropion


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: liver disorder


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:5790

subject_name: Hydromorphone


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: celiac disease


subject: CHEBI:6121

subject_name: Ketamine

object_name: bipolar disorder


subject: CHEBI:6121

object_name: bipolar depression


subject: CHEBI:6121

object_name: mood disorder


subject: CHEBI:6121

object_name: endogenous depression


subject: CHEBI:6121

object_name: major depressive disorder


subject: CHEBI:6121

object_name: bipolar II disorder


subject: CHEBI:6121

object_name: bipolar I disorder


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: Ischemic stroke


subject: CHEBI:68558


subject: CHEBI:6413

subject_name: Letrozole

object_name: breast neoplasm


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:94688

subject_name: Acipimox

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:94688

object_name: metabolic syndrome X


subject: UMLS:C2983764

object_name: Solid Neoplasm


subject: CHEBI:231693

subject_name: Capmatinib


subject: PR:000001543

subject_name: programmed cell death 1 ligand 1

object_name: basal cell carcinoma


subject: PR:000001543

object_name: skin basal cell carcinoma


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Stage III Rectal Cancer AJCC v6


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage III Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage III Rectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage II Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage II Rectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage II Rectal Cancer


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1169989

subject_name: buprenorphine / naloxone

object_name: opiate dependence


subject: CHEBI:167309

subject_name: Methadone


subject: MESH:C000620230

object_name: primary peritoneal carcinoma


subject: MESH:C000620230

object_name: Primary Peritoneal Cancer


subject: MESH:C000620230

object_name: fallopian tube cancer


subject: UMLS:C3273038


subject: UMLS:C3273038


subject: UMLS:C3273038


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Spasticity, CTCAE


subject: CHEBI:3160

object_name: Spasticity


subject: CHEBI:3160

object_name: stroke disorder


subject: CHEBI:3160

object_name: cerebrovascular disorder


subject: CHEBI:3160

object_name: Stroke (heart beat)


subject: CHEBI:3160

object_name: Stroke, CTCAE


subject: CHEBI:91368

subject_name: Enzastaurin

object_name: glioma


subject: CHEBI:91368

object_name: malignant glioma


subject: UMLS:C1615613


subject: UMLS:C1615613


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Post-Operative Pain


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: colorectal cancer


subject: CHEBI:4026

object_name: colorectal carcinoma


subject: CHEBI:4026

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:4026

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:4026

object_name: Embolism, Tumor


subject: CHEBI:4026

object_name: Neoplasm Metastasis


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:8772

subject_name: Raloxifene

object_name: schizophrenia


subject: CHEBI:8772

object_name: schizophreniform disorder


subject: CHEBI:8772

object_name: schizoaffective disorder


subject: CHEBI:8772

object_name: schizophrenia 18


subject: CHEBI:8772

object_name: psychosis


subject: CHEBI:8772

object_name: Nonorganic psychosis


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: castration-resistant prostate carcinoma


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:4672

subject_name: Docetaxel


subject: PUBCHEM.COMPOUND:3370

subject_name: Fludrocortisone acetate


subject: CHEBI:50885

subject_name: Fludrocortisone


subject: CHEBI:16962

subject_name: Cortisone


subject: CHEBI:83766

subject_name: Olaparib


subject: PUBCHEM.COMPOUND:135151902

subject_name: OPEVESOSTAT


subject: DRUGBANK:DB18818

subject_name: Opevesostat


subject: CHEBI:8382

subject_name: Prednisone


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:147912

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:147912

object_name: breast cancer


subject: PUBCHEM.COMPOUND:77528802

subject_name: Gepotidacin

object_name: bacterial infectious disease


subject: UNII:L08J2O299M

subject_name: Taselisib

object_name: Estrogen Receptor Positive


subject: UNII:L08J2O299M

object_name: Estrogen Receptor Negative


subject: UNII:L08J2O299M

object_name: triple-negative breast carcinoma


subject: UNII:L08J2O299M

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:L08J2O299M

object_name: Carcinoma breast stage IV


subject: UNII:L08J2O299M

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:L08J2O299M

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:L08J2O299M

object_name: Progesterone Receptor Positive


subject: UNII:L08J2O299M

object_name: HER2/Neu Negative


subject: UNII:L08J2O299M

object_name: Progesterone Receptor Negative


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: IgA vasculitis


subject: PUBCHEM.COMPOUND:139600705

subject_name: Pramlintide

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:139600705

object_name: obesity


subject: PUBCHEM.COMPOUND:139600705

object_name: Obesity, CTCAE


subject: UNII:TL60C27RLH

subject_name: Metreleptin


subject: UNII:TL60C27RLH


subject: UNII:TL60C27RLH


subject: CHEBI:82315

object_name: peripheral vascular disease


subject: CHEBI:82315

object_name: peripheral arterial disease


subject: CHEBI:28435


subject: CHEBI:28435


subject: CHEBI:943

subject_name: dichlobanil


subject: CHEBI:943


subject: DRUGBANK:DB14046

subject_name: Dichlorobenzene


subject: DRUGBANK:DB14046


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: Pleural Infection


subject: UMLS:C3540708

object_name: Pleural Infection, CTCAE


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: MESH:D000904


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540709


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C3540707


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540704


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540706


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540710


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C3540705


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Adult Rhabdomyosarcoma


subject: UMLS:C0919079

object_name: rhabdomyosarcoma


subject: UMLS:C0919079

object_name: Childhood Rhabdomyosarcoma


subject: UMLS:C0919079

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UMLS:C0919079

object_name: Childhood Neuroblastoma


subject: UMLS:C0919079

object_name: neuroblastoma


subject: UMLS:C0919079

object_name: medulloblastoma


subject: UMLS:C0919079

object_name: childhood medulloblastoma


subject: UMLS:C0919079

object_name: adult medulloblastoma


subject: UMLS:C0919079

object_name: hepatoblastoma


subject: UMLS:C0919079

object_name: liver carcinoma


subject: UMLS:C0919079

object_name: Solid Neoplasm


subject: UMLS:C0919079

object_name: Ewing sarcoma


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: UMLS:C5706520

subject_name: Oral Irinotecan Hydrochloride Formulation VAL-413


subject: UMLS:C5706520


subject: UMLS:C5706520


subject: UMLS:C5706520


subject: UMLS:C5706520


subject: UMLS:C5706520


subject: UMLS:C5706520


subject: UMLS:C5706520


subject: UMLS:C5706520


subject: UMLS:C5706520


subject: UMLS:C5706520


subject: UMLS:C5706520


subject: UMLS:C5706520


subject: CHEBI:37084

subject_name: beta-Hydroxyisovaleric acid

object_name: sarcopenia


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEMBL.COMPOUND:CHEMBL4297812

object_name: Viral upper respiratory tract infection


subject: UMLS:C0032375

subject_name: Oral Poliovirus Vaccine

object_name: Immunization reaction


subject: DRUGBANK:DB18595

object_name: diffuse cutaneous systemic sclerosis


subject: DRUGBANK:DB18595

object_name: diffuse scleroderma


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: liver cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: liver neoplasm


subject: PUBCHEM.COMPOUND:131769963

object_name: Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: diabetes mellitus


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:49960

subject_name: Vandetanib

object_name: carcinoma of urethra


subject: CHEBI:49960

object_name: urethra cancer


subject: CHEBI:49960

object_name: renal pelvis/ureter urothelial carcinoma


subject: CHEBI:49960

object_name: ureter cancer


subject: CHEBI:49960

object_name: ureter carcinoma


subject: CHEBI:49960

object_name: bladder tumor


subject: CHEBI:49960

object_name: urinary bladder carcinoma


subject: CHEBI:49960

object_name: urinary bladder cancer


subject: CHEBI:49960

object_name: childhood bladder carcinoma


subject: GTOPDB:7983

subject_name: lintuzumab

object_name: Myelodysplasia


subject: CHEMBL.COMPOUND:CHEMBL2109150

subject_name: LINTUZUMAB


subject: UMLS:C0530093


subject: UMLS:C4727210

subject_name: Cadonilimab

object_name: Small cell lung cancer extensive stage


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:4911

subject_name: Etoposide


subject: UMLS:C3642356

object_name: asthma


subject: UMLS:C3642356

object_name: viral disease


subject: UMLS:C3642356

object_name: Immunity, Innate


subject: UNII:08AN7WA2G0

subject_name: TRIPTORELIN PAMOATE

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:08AN7WA2G0

object_name: Malignant Solid Neoplasm


subject: UMLS:C1145204

subject_name: INJECTION, TRIPTORELIN PAMOATE, 3.75 MG ADMINISTERED


subject: UMLS:C1145204


subject: CHEBI:63633

subject_name: Triptorelin


subject: CHEBI:63633


subject: UMLS:C0112708

subject_name: Trelstar


subject: UMLS:C0112708


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: prostate carcinoma


subject: CHEBI:27812

object_name: No Evidence of Disease


subject: HMDB:HMDB0001349

subject_name: Selenium


subject: HMDB:HMDB0001349


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C0521939


subject: CHEBI:36796

subject_name: duloxetine

object_name: Depressed mood


subject: PUBCHEM.COMPOUND:155885731

subject_name: Maribavir

object_name: cytomegalovirus infection


subject: UNII:C3VX249T6L

subject_name: Ravulizumab

object_name: paroxysmal nocturnal hemoglobinuria


subject: UMLS:C4086207


subject: UNII:4801QYW816

subject_name: Gusacitinib

object_name: EXCESS LMW-DNA


subject: UMLS:C1681886

object_name: relapsing-remitting multiple sclerosis


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone


subject: PUBCHEM.COMPOUND:21879648

object_name: prostate cancer


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:137245

subject_name: Asp-Pro

object_name: malaria


subject: CHEBI:4653

subject_name: Dipyridamole


subject: CHEBI:74820

subject_name: Ser-Pro


subject: CHEBI:80308

subject_name: substance P


subject: PR:000016275

subject_name: trefoil factor 2


subject: UniProtKB:Q03404

subject_name: TFF2_MOUSE Trefoil factor 2 (sprot)


subject: UNII:QX6O64GP40

subject_name: Proxalutamide


subject: UNII:QX6O64GP40

object_name: severe acute respiratory syndrome


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: chronic kidney disease


subject: CHEBI:28939

object_name: Chronic uremia


subject: CHEBI:28939

object_name: Brainstem death


subject: CHEBI:28939

object_name: Brain Death


subject: CHEBI:94782

subject_name: Cediranib

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:94782

object_name: Recurrent ovarian cancer


subject: CHEBI:94782

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:94782

object_name: Undifferentiated Fallopian Tube Carcinoma


subject: CHEBI:94782

object_name: primary peritoneal serous adenocarcinoma


subject: CHEBI:94782

object_name: peritoneal serous adenocarcinoma


subject: CHEBI:94782

object_name: fallopian tube transitional cell carcinoma


subject: CHEBI:94782

object_name: fallopian tube clear cell adenocarcinoma


subject: CHEBI:94782

object_name: fallopian tube serous adenocarcinoma


subject: CHEBI:94782

object_name: ovarian transitional cell carcinoma


subject: CHEBI:94782

object_name: fallopian tube endometrioid adenocarcinoma


subject: CHEBI:94782

object_name: undifferentiated ovarian carcinoma


subject: CHEBI:94782

object_name: ovarian clear cell adenocarcinoma


subject: CHEBI:94782

object_name: ovarian seromucinous carcinoma


subject: CHEBI:94782

object_name: ovarian endometrioid adenocarcinoma


subject: CHEBI:94782

object_name: ovarian serous adenocarcinoma


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE


subject: UNII:68AYS9A614


subject: UNII:68AYS9A614


subject: UNII:68AYS9A614


subject: UNII:68AYS9A614


subject: UNII:68AYS9A614


subject: UNII:68AYS9A614


subject: UNII:68AYS9A614


subject: UNII:68AYS9A614


subject: UNII:68AYS9A614


subject: UNII:68AYS9A614


subject: UNII:68AYS9A614


subject: UNII:68AYS9A614


subject: UNII:68AYS9A614


subject: UNII:68AYS9A614


subject: UNII:68AYS9A614


subject: UMLS:C2711999

subject_name: cediranib maleate


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: uterine fibroid


subject: CHEBI:94518

object_name: leiomyoma


subject: CHEBI:176724

subject_name: Etiracetam

object_name: epilepsy


subject: CHEBI:176724

object_name: diabetic kidney disease


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: UNII:73HC18Y1LW


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6437


subject: CHEBI:31355

subject_name: Carboplatin

object_name: breast neoplasm


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:64816


subject: CHEBI:91872


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: small intestinal bacterial overgrowth


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: UMLS:C3658787

object_name: HIV-1 infection


subject: UNII:EXL0L74IKU


subject: CHEBI:2704

subject_name: Anastrozole

object_name: Childhood Breast Carcinoma


subject: CHEBI:2704

object_name: breast carcinoma


subject: CHEBI:2704

object_name: breast cancer


subject: CHEBI:4026

object_name: Fanconi anemia


subject: CHEBI:4026

object_name: Fanconi anemia complementation group A


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:4026

object_name: diffuse large B-cell lymphoma


subject: CHEBI:4026

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:4026

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:60654

subject_name: valproate


subject: CHEBI:60654


subject: CHEBI:60654


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: GTOPDB:12989

subject_name: toripalimab

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: GTOPDB:12989

object_name: peripheral T-cell lymphoma, not otherwise specified


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: CHEBI:135918

subject_name: Tucidinostat


subject: CHEBI:135918


subject: CHEBI:9168

subject_name: Sirolimus

object_name: HIV infection


subject: CHEBI:184662


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEBI:63608

subject_name: Maraviroc


subject: CHEBI:50861

subject_name: Treprostinil

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:50861

object_name: pulmonary hypertension


subject: CHEBI:50861

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:50861

object_name: pulmonary arterial hypertension


subject: CHEMBL.COMPOUND:CHEMBL4594461

subject_name: AUTOLOGOUS CORD BLOOD

object_name: traumatic encephalopathy


subject: CHEMBL.COMPOUND:CHEMBL4594461

object_name: traumatic brain injury


subject: CHEBI:176381

subject_name: Diosmin

object_name: Venous insufficiency of leg


subject: UNII:XRO4566Q4R

subject_name: INTERFERON BETA


subject: UMLS:C0594372

subject_name: Avonex


subject: CHEBI:5938

subject_name: Interferon beta-1b


subject: UNII:QC4F7FKK7I

subject_name: Faricimab

object_name: diabetic macular edema


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: DRUGBANK:DB16582

subject_name: Lisocabtagene maraleucel


subject: CHEBI:231222

subject_name: Cebranopadol

object_name: Acute Pain


subject: UNII:7GDW9S3GN3


subject: UMLS:C3827125


subject: CHEBI:28741

subject_name: Sodium fluoride

object_name: Early childhood caries


subject: UMLS:C1171560

subject_name: Natrium fluoratum, sodium fluoride, Homeopathic preparation


subject: UMLS:C1120338

subject_name: casein phosphopeptide-amorphous calcium phosphate nanocomplex


subject: CHEBI:28755


subject: CHEBI:143794


subject: CHEBI:64610

subject_name: Tenocyclidine


subject: CHEBI:6824

subject_name: Methenamine

object_name: urinary tract infection


subject: CHEBI:6824

object_name: Recurrent urinary tract infections


subject: CHEBI:6824

object_name: Catheter related infection


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: varicose veins


subject: MESH:D006495

object_name: venous thromboembolism


subject: MESH:D006495

object_name: thrombophilia due to thrombin defect


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: UMLS:C3536766


subject: UMLS:C3536766


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: brain neoplasm


subject: CHEBI:201431

object_name: central nervous system cancer


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: malignant urinary system neoplasm


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: septic shock


subject: CHEBI:50885

subject_name: Fludrocortisone


subject: UMLS:C1170000

subject_name: drotrecogin alfa


subject: MESH:D010919

subject_name: Placebos


subject: UNII:65O9DMS368

object_name: intermittent vascular claudication


subject: UNII:65O9DMS368

object_name: peripheral vascular disease


subject: DRUGBANK:DB05505


subject: DRUGBANK:DB05505


subject: CHEBI:50218

subject_name: EC 3.1.4.* (phosphoric diester hydrolase) inhibitor


subject: CHEBI:50218


subject: UMLS:C0031638

subject_name: Phosphodiesterase Inhibitors


subject: UMLS:C0031638


subject: CHEBI:52172

subject_name: Nilotinib

object_name: Plexosarcoma


subject: UMLS:C4287690

subject_name: BET Bromodomain Inhibitor ZEN-3694

object_name: Metastatic Colorectal Adenocarcinoma


subject: UMLS:C4287690

object_name: Stage IV Colorectal Cancer AJCC v8


subject: UMLS:C4287690

object_name: Refractory Colorectal Adenocarcinoma


subject: UMLS:C4287690

object_name: Recurrent Colorectal Adenocarcinoma


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UNII:8L7891MRB6

subject_name: Encorafenib


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: melanoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:75998

subject_name: Trametinib


subject: PR:000013941

subject_name: regucalcin

object_name: Buruli Ulcer


subject: PR:000008606

subject_name: transcription factor HIVEP3


subject: CHEBI:487869

subject_name: clavulanate


subject: CHEBI:48947

subject_name: Clavulanic acid


subject: UNII:6R5034F862

object_name: atopic eczema


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: no feeling or sensation of skin


subject: CHEBI:4466

object_name: Sensory Loss


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:119915


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: UMLS:C5667079

subject_name: Anti-EGFR/anti-HER3 Antibody-drug Conjugate BL-B01D1

object_name: urothelial carcinoma


subject: UMLS:C5667079

object_name: transitional cell carcinoma


subject: UMLS:C5667079

object_name: Childhood Solid Neoplasm


subject: UMLS:C5667079

object_name: Adult Solid Neoplasm


subject: UMLS:C5667079

object_name: Solid Neoplasm


subject: UMLS:C5555042

subject_name: Danvilostomig


subject: UMLS:C5555042


subject: UMLS:C5555042


subject: UMLS:C5555042


subject: UMLS:C5555042


subject: CHEBI:6121

subject_name: Ketamine

object_name: Postoperative cognitive dysfunction


subject: CHEBI:132774

subject_name: Roxadustat

object_name: Renal anaemia


subject: UMLS:C3713379


subject: UMLS:C4043276

object_name: Castration-Sensitive Prostate Carcinoma


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Hematoma, Subdural, Chronic


subject: UMLS:C3641862

object_name: uveal melanoma


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: Childhood Breast Carcinoma


subject: CHEBI:135918

object_name: breast carcinoma


subject: CHEBI:135918

object_name: breast cancer


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)


subject: UMLS:C4086713


subject: UMLS:C4086713


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UNII:GKF8S4C432

subject_name: Anlotinib


subject: UNII:GKF8S4C432


subject: UNII:GKF8S4C432


subject: CHEBI:231356

subject_name: Varlitinib

object_name: Advanced cancer


subject: UMLS:C4759996

subject_name: Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance)


subject: CHEBI:31348

subject_name: Capecitabine


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: vitamin D deficiency


subject: PUBCHEM.COMPOUND:2735

object_name: Bone density below reference range (finding)


subject: PUBCHEM.COMPOUND:2735

object_name: Osteopenia


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: MESH:D002136

subject_name: Calcium, Dietary


subject: MESH:D002136


subject: MESH:D002136


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:22984


subject: CHEBI:22984


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: CHEBI:6801

subject_name: Metformin

object_name: fragile X syndrome


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: HER2-positive gastric cancer


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: GTOPDB:13627

subject_name: zanidatamab


subject: UNII:Z20OC92TDI

subject_name: ZANIDATAMAB


subject: UMLS:C4331966


subject: CHEBI:4445

subject_name: Desflurane

object_name: Idiopathic scoliosis and kyphoscoliosis


subject: CHEBI:4445

object_name: idiopathic scoliosis


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: UMLS:C4684945

subject_name: Semuloparin Sodium

object_name: venous thromboembolism


subject: UMLS:C4684945

object_name: thrombophilia due to thrombin defect


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: age-related macular degeneration


subject: CHEBI:64816

object_name: Hodgkin Disease


subject: CHEBI:64816

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:64816

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: anemia deficiency iron treatment


subject: UMLS:C1440867

subject_name: lactoferrin, bovine


subject: UNII:4CA9IAU7RJ

object_name: HIV infection


subject: CHEBI:38559

subject_name: cytochrome P450


subject: UMLS:C0010762

subject_name: Cytochrome P450


subject: UMLS:C1709443

subject_name: Rose Bengal Solution PV-10

object_name: Childhood Breast Carcinoma


subject: UMLS:C1709443

object_name: breast carcinoma


subject: UMLS:C1709443

object_name: breast cancer


subject: PUBCHEM.COMPOUND:6436143

subject_name: Adenosylcobalamin

object_name: malnutrition


subject: CHEBI:18408

subject_name: Cobamamide


subject: UNII:F0R1QK73KB

subject_name: cobamamide


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Kaposi Sarcoma


subject: CHEBI:45863

object_name: HIV-1 infection


subject: CHEBI:28748


subject: CHEBI:28748


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: neuroendocrine carcinoma


subject: UNII:DPT0O3T46P

object_name: High grade neuroendocrine carcinoma, any site


subject: UNII:DPT0O3T46P

object_name: pulmonary large cell neuroendocrine carcinoma


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: ST-elevation myocardial infarction


subject: CHEBI:68558

subject_name: Ticagrelor


subject: CHEBI:6121

subject_name: Ketamine

object_name: schizophrenia


subject: UNII:9G1A824CC2


subject: CHEBI:6933

subject_name: Midodrine

object_name: Chronic liver disease


subject: PUBCHEM.COMPOUND:23709079

subject_name: Treximet

object_name: migraine


subject: PUBCHEM.COMPOUND:23709079

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:7476


subject: CHEBI:85083

subject_name: Sofosbuvir

object_name: hepatitis C


subject: PUBCHEM.COMPOUND:66621102


subject: CHEBI:85089

subject_name: Ledipasvir


subject: CHEBI:3777

subject_name: Coagulation Factor VIIa

object_name: hemophilia A


subject: CHEBI:3777

object_name: hemophilia


subject: CHEMBL.COMPOUND:CHEMBL2108334

subject_name: Coagulation factor VIIa Recombinant Human


subject: CHEMBL.COMPOUND:CHEMBL2108334


subject: UMLS:C0593103

subject_name: Novoseven


subject: UMLS:C0593103


subject: UMLS:C0015505

subject_name: factor VIIa


subject: UMLS:C0015505


subject: CHEBI:6121

object_name: alcohol abuse


subject: CHEBI:6121

object_name: alcohol dependence


subject: CHEBI:7465

subject_name: Naltrexone

object_name: endogenous depression


subject: CHEBI:7465

object_name: major depressive disorder


subject: UNII:BPQ010OFD7

subject_name: RALUDOTATUG DERUXTECAN

object_name: digestive system cancer


subject: UMLS:C5555533

subject_name: Anti-CDH-6 ADC DS-6000a


subject: UNII:DOB7Y3RSX0

subject_name: HPPH

object_name: carcinoma of esophagus


subject: UNII:DOB7Y3RSX0

object_name: esophageal cancer


subject: UNII:DOB7Y3RSX0

object_name: Childhood Esophageal Carcinoma


subject: UNII:DOB7Y3RSX0

object_name: neoplasm of esophagus


subject: UNII:DOB7Y3RSX0

object_name: precancerous condition


subject: UNII:55F75LJQ0V

subject_name: ANAMORELIN HYDROCHLORIDE

object_name: Malignant cachexia


subject: UNII:55F75LJQ0V

object_name: non-small cell lung carcinoma


subject: UMLS:C2346777

subject_name: RC-1291 HCl


subject: UMLS:C2346777


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Cholangiocarcinoma non-resectable


subject: PUBCHEM.COMPOUND:2767

object_name: Cholangiocarcinoma recurrent


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Intrahepatic Cholangiocarcinoma AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Hilar Cholangiocarcinoma AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Hilar Cholangiocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Hilar Cholangiocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Hilar Cholangiocarcinoma AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Hilar Cholangiocarcinoma AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Hilar Cholangiocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA Hilar Cholangiocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA Hilar Cholangiocarcinoma AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Extrahepatic Bile Duct Cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Extrahepatic bile duct cancer stage III


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Extrahepatic Bile Duct Cancer


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Cholangiocarcinoma non-resectable


subject: CHEBI:175901

object_name: Cholangiocarcinoma recurrent


subject: CHEBI:175901

object_name: Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7


subject: CHEBI:175901

object_name: Stage III Intrahepatic Cholangiocarcinoma AJCC v7


subject: CHEBI:175901

object_name: Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7


subject: CHEBI:175901

object_name: Stage IVA Hilar Cholangiocarcinoma AJCC v7


subject: CHEBI:175901

object_name: Stage IVA Hilar Cholangiocarcinoma AJCC v8


subject: CHEBI:175901

object_name: Stage IVB Hilar Cholangiocarcinoma AJCC v8


subject: CHEBI:175901

object_name: Stage IVB Hilar Cholangiocarcinoma AJCC v7


subject: CHEBI:175901

object_name: Stage IIIB Hilar Cholangiocarcinoma AJCC v7


subject: CHEBI:175901

object_name: Stage IIIB Hilar Cholangiocarcinoma AJCC v8


subject: CHEBI:175901

object_name: Stage IIIA Hilar Cholangiocarcinoma AJCC v8


subject: CHEBI:175901

object_name: Stage IIIA Hilar Cholangiocarcinoma AJCC v7


subject: CHEBI:175901

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: CHEBI:175901

object_name: Stage IVB Extrahepatic Bile Duct Cancer


subject: CHEBI:175901

object_name: Extrahepatic bile duct cancer stage III


subject: CHEBI:175901

object_name: Stage IVA Extrahepatic Bile Duct Cancer


subject: CHEBI:95073

subject_name: Ricolinostat

object_name: Cholangiocarcinoma non-resectable


subject: CHEBI:95073

object_name: Cholangiocarcinoma recurrent


subject: CHEBI:95073

object_name: Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7


subject: CHEBI:95073

object_name: Stage III Intrahepatic Cholangiocarcinoma AJCC v7


subject: CHEBI:95073

object_name: Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7


subject: CHEBI:95073

object_name: Stage IVA Hilar Cholangiocarcinoma AJCC v7


subject: CHEBI:95073

object_name: Stage IVA Hilar Cholangiocarcinoma AJCC v8


subject: CHEBI:95073

object_name: Stage IVB Hilar Cholangiocarcinoma AJCC v8


subject: CHEBI:95073

object_name: Stage IVB Hilar Cholangiocarcinoma AJCC v7


subject: CHEBI:95073

object_name: Stage IIIB Hilar Cholangiocarcinoma AJCC v7


subject: CHEBI:95073

object_name: Stage IIIB Hilar Cholangiocarcinoma AJCC v8


subject: CHEBI:95073

object_name: Stage IIIA Hilar Cholangiocarcinoma AJCC v8


subject: CHEBI:95073

object_name: Stage IIIA Hilar Cholangiocarcinoma AJCC v7


subject: CHEBI:95073

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: CHEBI:95073

object_name: Stage IVB Extrahepatic Bile Duct Cancer


subject: CHEBI:95073

object_name: Extrahepatic bile duct cancer stage III


subject: CHEBI:95073

object_name: Stage IVA Extrahepatic Bile Duct Cancer


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Childhood Solid Neoplasm


subject: GTOPDB:12990

object_name: Adult Solid Neoplasm


subject: GTOPDB:12990

object_name: Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: CHEBI:2453

subject_name: Acyclovir

object_name: genital herpes


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Locally Advanced Head and Neck Squamous Cell Carcinoma


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4742319

subject_name: Yangxinshi tablet

object_name: Chronic coronary syndrome


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Nasal Polyp


subject: CHEBI:4466

object_name: irregular; nasal septum


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:6121


subject: CHEBI:9435

subject_name: Temazepam

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: urinary tract infection


subject: PUBCHEM.COMPOUND:3467

object_name: Recurrent urinary tract infections


subject: PUBCHEM.COMPOUND:3467

object_name: Sepsis


subject: PUBCHEM.COMPOUND:3467

object_name: Sepsis, CTCAE


subject: UNII:9603LN7R2Q

subject_name: Creatine Monohydrate

object_name: endogenous depression


subject: UNII:9603LN7R2Q

object_name: major depressive disorder


subject: CHEBI:16919

subject_name: Creatine


subject: CHEBI:16919


subject: UMLS:C5854568

subject_name: Oncolytic HSV-1 R130

object_name: ovarian cancer


subject: UMLS:C5854568

object_name: ovarian neoplasm


subject: UMLS:C5854568

object_name: ovarian carcinoma


subject: UMLS:C5854568

object_name: fallopian tube carcinoma


subject: UMLS:C5854568

object_name: fallopian tube cancer


subject: UMLS:C5854568

object_name: peritoneal carcinomatosis


subject: UMLS:C3492697

object_name: Alzheimer disease


subject: UMLS:C3273712

subject_name: ponezumab


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:194186

object_name: obesity


subject: CHEBI:194186

object_name: Obesity, CTCAE


subject: UMLS:C0295415

subject_name: rituximab

object_name: rheumatoid arthritis


subject: CHEBI:85082

subject_name: Harvoni

object_name: hepatitis C


subject: CHEBI:85082

object_name: HIV infection


subject: CHEBI:85082

object_name: Cirrhosis


subject: CHEBI:85082

object_name: liver cirrhosis


subject: RXCUI:1591939

subject_name: ledipasvir / sofosbuvir Oral Product


subject: RXCUI:1591939


subject: RXCUI:1591939


subject: RXCUI:1591939


subject: CHEBI:53760

subject_name: Eszopiclone

object_name: Primary Insomnia


subject: CHEBI:8707

subject_name: Quetiapine

object_name: bipolar disorder


subject: CHEBI:8707

object_name: cocaine dependence


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: recurrent adult acute myeloid leukemia


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB05801


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: treatment-refractory schizophrenia


subject: UNII:4F4X42SYQ6

object_name: Schizophrenia Spectrum and Other Psychotic Disorders


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Postoperative Nausea


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: plasma cell myeloma


subject: CHEBI:41879


subject: CHEBI:52717

subject_name: Bortezomib


subject: UNII:Q3NN3EB8VY

subject_name: CLOSTRIDIUM BUTYRICUM

object_name: acne


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Malignant neoplasm of stomach stage IV


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UMLS:C3253393

object_name: osteoporosis


subject: UMLS:C3253393

object_name: Encounter due to family history of osteoporosis


subject: UMLS:C3253393

object_name: Osteoporosis, CTCAE 5.0


subject: UMLS:C3253393

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C5782830

subject_name: ROPivacaine 0.5% injectable solution

object_name: Hip arthropathy


subject: UMLS:C5782830

object_name: osteoarthritis, hip


subject: UMLS:C5782830

object_name: hip pain chronic


subject: UMLS:C5782830

object_name: Disorder of hip region


subject: CHEBI:201756

subject_name: Clindamycin 2-Phosphate


subject: CHEBI:3745

subject_name: clindamycin


subject: CHEBI:82405

subject_name: Benzoyl peroxide


subject: UMLS:C5549318

subject_name: Hibiscus tea antigen

object_name: asthenopia


subject: UMLS:C5549318

object_name: myopia


subject: UMLS:C5549318

object_name: body fat percentage (physical finding)


subject: UMLS:C5549318

object_name: Body Composition


subject: UMLS:C5549318

object_name: Blood Pressure Finding


subject: UMLS:C5549318

object_name: Systemic arterial pressure


subject: CHEBI:68590

subject_name: fidaxomicin

object_name: Clostridium difficile colitis


subject: CHEBI:68590

object_name: clostridium difficile infection


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: chronic obstructive pulmonary disease


subject: UNII:90Z2UF0E52

object_name: bronchitis


subject: UNII:90Z2UF0E52

object_name: Acute bronchitis


subject: UNII:90Z2UF0E52

object_name: chronic airways limitation


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Malignant neoplasm of pancreas resectable


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: UNII:KXG2PJ551I

subject_name: Avelumab


subject: UMLS:C3896806


subject: UNII:BHV7HS9CF3

subject_name: EXIDAVNEMAB

object_name: multiple system atrophy


subject: UNII:BHV7HS9CF3

object_name: Parkinson disease


subject: UMLS:C5669598

subject_name: Exidavnemab


subject: UMLS:C5669598


subject: CHEBI:33374

subject_name: Samarium

object_name: lung cancer


subject: CHEBI:33374

object_name: lung neoplasm


subject: CHEBI:33374

object_name: lung carcinoma


subject: CHEBI:33374

object_name: Childhood Breast Carcinoma


subject: CHEBI:33374

object_name: breast carcinoma


subject: CHEBI:33374

object_name: breast cancer


subject: CHEBI:33374

object_name: prostate carcinoma


subject: CHEBI:33374

object_name: prostate cancer


subject: CHEBI:33374

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:33374

object_name: Embolism, Tumor


subject: CHEBI:33374

object_name: Neoplasm Metastasis


subject: CHEMBL.COMPOUND:CHEMBL4650397

object_name: Alzheimer disease type 1


subject: CHEMBL.COMPOUND:CHEMBL4650397

object_name: Alzheimer disease


subject: CHEBI:8874

subject_name: Rivastigmine

object_name: substance-related disorder


subject: PUBCHEM.COMPOUND:2307

subject_name: Andion

object_name: asthma


subject: CHEBI:3001

subject_name: beclomethasone


subject: CHEBI:176724

subject_name: Etiracetam

object_name: anxiety disorder


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:139072

object_name: Psychedelic Experiences


subject: CHEBI:139072

object_name: Consciousness Disorders


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEBI:9168

subject_name: Sirolimus

object_name: euthyroid Graves orbitopathy


subject: CHEBI:9168

object_name: endocrine exophthalmos


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Cicatrization


subject: CHEBI:36791

subject_name: Escitalopram

object_name: cocaine dependence


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:132082

subject_name: Entinostat

object_name: pancreatic neoplasm


subject: CHEBI:132082

object_name: exocrine pancreatic carcinoma


subject: CHEBI:132082

object_name: malignant pancreatic neoplasm


subject: CHEBI:132774

subject_name: Roxadustat

object_name: Anemia in end stage renal disease


subject: UMLS:C3713379


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:596

object_name: myeloid leukemia


subject: UMLS:C0733521

subject_name: Ara-C


subject: UMLS:C0733521


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:45783

subject_name: Imatinib


subject: CHEBI:45783


subject: UNII:6ZA31Y954Z

subject_name: Brodalumab


subject: UNII:82M942WZ4A

object_name: cystic fibrosis


subject: UMLS:C1143399


subject: CHEBI:49956

subject_name: Xenon

object_name: ischemic brain injury


subject: UMLS:C5434105

subject_name: Injection, sacituzumab govitecan-hziy, 2.5 mg

object_name: triple-negative breast carcinoma


subject: UMLS:C5434105

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: CHEBI:231087

subject_name: Trilaciclib


subject: CHEBI:231087


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Metastatic malignant neoplasm to liver


subject: PUBCHEM.COMPOUND:14907381

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:14907381

object_name: colorectal adenocarcinoma


subject: CHEBI:80961


subject: CHEBI:80961


subject: CHEBI:80961


subject: CHEBI:80961


subject: CHEBI:80961


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UNII:6A901E312A

subject_name: Panitumumab


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:82960

subject_name: Raltegravir

object_name: HIV infection


subject: CHEMBL.COMPOUND:CHEMBL2219773

subject_name: CUSTIRSEN SODIUM

object_name: prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2219773

object_name: prostate cancer


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:58097

object_name: heart; dysfunction postoperative, cardiac surgery


subject: CHEBI:17303

subject_name: Morphine


subject: UMLS:C1602113

subject_name: OxyNorm


subject: UMLS:C3641626

subject_name: Targin


subject: CHEBI:142094

subject_name: (S)-S-adenosyl-L-methionine zwitterion


subject: CHEBI:15414

subject_name: Adomet


subject: CHEBI:67040

subject_name: Ademetionine


subject: CHEBI:174428


subject: CHEBI:77590

subject_name: Armodafinil

object_name: endogenous depression


subject: CHEBI:77590

object_name: major depressive disorder


subject: CHEBI:77590

object_name: obstructive sleep apnea syndrome


subject: CHEBI:77590

object_name: dysthymic disorder


subject: CHEBI:77590

object_name: sleep disorder


subject: CHEBI:31859

subject_name: Modafinil


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Surgical Wound Infection


subject: MESH:C515331

subject_name: DuraPrep


subject: CHEBI:145371

subject_name: Binimetinib

object_name: Childhood Solid Neoplasm


subject: CHEBI:145371

object_name: Adult Solid Neoplasm


subject: CHEBI:145371

object_name: Solid Neoplasm


subject: CHEBI:145371

object_name: non-small cell lung carcinoma


subject: UNII:T21N67B1V3


subject: UNII:T21N67B1V3


subject: UNII:T21N67B1V3


subject: UNII:T21N67B1V3


subject: UMLS:C5236067

subject_name: SHP2 Inhibitor JAB-3312


subject: UMLS:C5236067


subject: UMLS:C5236067


subject: UMLS:C5236067


subject: CHEBI:90943

subject_name: Osimertinib


subject: CHEBI:90943


subject: CHEBI:90943


subject: CHEBI:178199

subject_name: Sotorasib


subject: CHEBI:178199


subject: CHEBI:178199


subject: CHEBI:178199


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: colorectal cancer


subject: CHEBI:68646

object_name: colorectal carcinoma


subject: CHEBI:68646

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:65173

subject_name: Iloperidone

object_name: schizophrenia


subject: UNII:QQA9MLH692

subject_name: Tafasitamab

object_name: Acute lymphocytic leukaemia refractory


subject: UNII:QQA9MLH692

object_name: Acute lymphoid leukemia relapse


subject: UNII:QQA9MLH692

object_name: B-cell childhood acute lymphoblastic leukemia


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: CHEBI:31781

subject_name: Lopinavir


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:135919

subject_name: Nesiritide

object_name: heart failure


subject: CHEBI:135919

object_name: congestive heart failure


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: indolent B-cell non-Hodgkin lymphoma


subject: UNII:DPT0O3T46P

object_name: follicular lymphoma


subject: UNII:DPT0O3T46P

object_name: marginal zone lymphoma


subject: UNII:DPT0O3T46P

object_name: MALT lymphoma


subject: UNII:15FIX9V2JP

subject_name: TITANIUM DIOXIDE

object_name: dentin caries


subject: UNII:15FIX9V2JP

object_name: dental caries


subject: UNII:15FIX9V2JP

object_name: Dental Caries, CTCAE


subject: UNII:15FIX9V2JP

object_name: Reversible pulpitis


subject: UNII:15FIX9V2JP

object_name: Caries (morphologic abnormality)


subject: UNII:15FIX9V2JP

object_name: pulpitis


subject: CHEBI:32234

subject_name: Titanium dioxide


subject: CHEBI:32234


subject: CHEBI:32234


subject: CHEBI:32234


subject: CHEBI:32234


subject: CHEBI:32234


subject: CHEBI:31359

subject_name: carubicin

object_name: Diabetic Neuralgia


subject: CHEBI:6121

subject_name: Ketamine

object_name: Sedation


subject: CHEBI:6121

object_name: Sedated


subject: CHEBI:6121

object_name: Mechanical ventilation finding


subject: CHEBI:6121

object_name: Critical Illness


subject: CHEBI:68584

subject_name: Ezogabine

object_name: Seizure Related to COVID-19


subject: CHEBI:68584

object_name: epilepsy


subject: CHEBI:68584

object_name: visual epilepsy


subject: CHEBI:230430

subject_name: Ulinastatin

object_name: acute respiratory distress syndrome


subject: CHEBI:230430

object_name: adult acute respiratory distress syndrome


subject: UNII:OR3S9IF86U

subject_name: urinastatin


subject: UNII:OR3S9IF86U


subject: CHEMBL.COMPOUND:CHEMBL2108163

subject_name: ULINASTATIN


subject: CHEMBL.COMPOUND:CHEMBL2108163


subject: UMLS:C0077906


subject: UMLS:C0077906


subject: CHEBI:139072

object_name: treatment resistant depression


subject: CHEBI:139072


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: chronic progressive multiple sclerosis


subject: UNII:3DRR0X4728

subject_name: Clazosentan

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Neck Carcinoma


subject: CHEBI:231679

object_name: head and neck neoplasm


subject: CHEBI:231679

object_name: head and neck cancer


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:DPT0O3T46P

object_name: metastatic malignant neoplasm in the brain


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: non-small cell lung carcinoma


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V

object_name: melanoma


subject: CHEBI:27470

subject_name: Folic acid

object_name: bladder tumor


subject: CHEBI:27470

object_name: urinary bladder carcinoma


subject: CHEBI:27470

object_name: urinary bladder cancer


subject: CHEBI:27470

object_name: childhood bladder carcinoma


subject: CHEBI:27470

object_name: transitional cell carcinoma


subject: UMLS:C5203275

subject_name: Pralatrexate Liquid Injection


subject: UMLS:C5203275


subject: UMLS:C5203275


subject: UMLS:C5203275


subject: UMLS:C5203275


subject: UMLS:C2959279

subject_name: Injection, pralatrexate, 1 mg


subject: UMLS:C2959279


subject: UMLS:C2959279


subject: UMLS:C2959279


subject: UMLS:C2959279


subject: CHEBI:71223

subject_name: Pralatrexate


subject: CHEBI:71223


subject: CHEBI:71223


subject: CHEBI:71223


subject: CHEBI:71223


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: CHEBI:28911


subject: CHEBI:28911


subject: CHEBI:28911


subject: CHEBI:28911


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: CHEBI:176843


subject: CHEBI:176843


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: CHEBI:230016

object_name: adult acute myeloid leukemia


subject: CHEBI:230016

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:230016

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:230016

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:230016

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:230016

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:230016

object_name: recurrent adult acute myeloid leukemia


subject: UNII:0NIZ8H6OL8

subject_name: Tetrahydrouridine


subject: UNII:0NIZ8H6OL8


subject: UNII:0NIZ8H6OL8


subject: UNII:0NIZ8H6OL8


subject: UNII:0NIZ8H6OL8


subject: UNII:0NIZ8H6OL8


subject: UNII:0NIZ8H6OL8


subject: UMLS:C1314420

subject_name: INJECTION, RASBURICASE, 0.5 MG ADMINISTERED

object_name: Hyperuricemia


subject: UMLS:C1314420

object_name: Hyperuricemia, CTCAE


subject: UNII:08GY9K1EUO

subject_name: Rasburicase


subject: UNII:08GY9K1EUO


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: CHEBI:8382

subject_name: Prednisone

object_name: lung disorder


subject: CHEBI:8382

object_name: History of - respiratory disease


subject: CHEBI:44915

subject_name: Propofol

object_name: post operative nausea and vomiting


subject: UMLS:C1827106

subject_name: Dipeptidyl-Peptidase IV Inhibitors

object_name: Arterial Stiffness


subject: UNII:WTT295HSY5

subject_name: Dulaglutide


subject: UMLS:C2976495


subject: UMLS:C5448109

object_name: Wilson disease


subject: CHEBI:3219

subject_name: Bupropion


subject: UNII:681K1JDI8M

subject_name: Valoctocogene roxaparvovec

object_name: hemophilia A


subject: MESH:D000077325

subject_name: Ringer's Lactate

object_name: osteoarthritis


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB

object_name: bladder tumor


subject: UNII:DLE8519RWM

object_name: urinary bladder carcinoma


subject: UNII:DLE8519RWM

object_name: urinary bladder cancer


subject: UNII:DLE8519RWM

object_name: childhood bladder carcinoma


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza

object_name: hypertriglyceridemia


subject: PUBCHEM.COMPOUND:9831414

object_name: Hypertriglyceridemia, CTCAE


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:D87YGH4Z0Q


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: CHEBI:231673

subject_name: Hyaluronidase

object_name: scleroderma


subject: CHEBI:231673

object_name: systemic sclerosis


subject: CHEBI:231673

object_name: Narrow mouth


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: CHEBI:5132

subject_name: Flutamide

object_name: Androgen excess


subject: UNII:306QR91I9R

subject_name: Pelabresib

object_name: Childhood Solid Neoplasm


subject: UNII:306QR91I9R

object_name: Adult Solid Neoplasm


subject: UNII:306QR91I9R

object_name: Solid Neoplasm


subject: UNII:306QR91I9R

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:306QR91I9R

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:306QR91I9R

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:189653

subject_name: pelabresib


subject: CHEBI:189653


subject: CHEBI:189653


subject: CHEBI:189653


subject: CHEBI:189653


subject: CHEBI:189653


subject: UMLS:C5707688


subject: UMLS:C5707688


subject: UMLS:C5707688


subject: UMLS:C5707688


subject: UMLS:C5707688


subject: UMLS:C5707688


subject: GTOPDB:8313

subject_name: talazoparib

object_name: ovarian cancer


subject: GTOPDB:8313

object_name: ovarian neoplasm


subject: GTOPDB:8313

object_name: ovarian carcinoma


subject: MESH:D022242

subject_name: Pneumococcal Vaccines

object_name: streptococcal infection


subject: UMLS:C5240157

subject_name: Vaccine product containing only Streptococcus pneumoniae antigen (medicinal product)


subject: PUBCHEM.COMPOUND:152165

object_name: alcohol abuse


subject: PUBCHEM.COMPOUND:152165

object_name: alcohol dependence


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:47381


subject: CHEBI:85989

subject_name: Avycaz

object_name: Acute-On-Chronic Liver Failure


subject: CHEBI:85989

object_name: acute-on-chronic liver failure


subject: UMLS:C3656596

subject_name: avibactam / ceftazidime


subject: UMLS:C3656596


subject: UMLS:C5447482

subject_name: Ligufalimab

object_name: cancer


subject: UMLS:C5447482

object_name: nervous system cancer


subject: CHEBI:167574

subject_name: Semaglutide

object_name: type 2 diabetes mellitus


subject: CHEBI:167574

object_name: Diabetes


subject: CHEBI:167574

object_name: diabetes mellitus


subject: CHEBI:32139

object_name: acute kidney failure


subject: CHEBI:64312

subject_name: Memantine

object_name: Alzheimer disease


subject: CHEBI:40968

subject_name: Astaxanthin

object_name: stroke disorder


subject: CHEBI:40968

object_name: Increased reactive oxygen species production


subject: MESH:D022242

object_name: HIV infection


subject: UMLS:C1134664


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: lung cancer


subject: CHEBI:91397

object_name: lung neoplasm


subject: CHEBI:91397

object_name: lung carcinoma


subject: CHEBI:134718

subject_name: Safinamide

object_name: multiple system atrophy


subject: UNII:NX3NW9MM9W

subject_name: VISUGROMAB

object_name: Metastatic Lung Non-Squamous Non-Small Cell Carcinoma


subject: UNII:NX3NW9MM9W

object_name: Adult Solid Neoplasm


subject: UMLS:C5555769

subject_name: Visugromab


subject: UMLS:C5555769


subject: UMLS:C0003234

subject_name: Anthracycline Antibiotics

object_name: breast neoplasm


subject: CHEBI:48120

subject_name: anthracycline


subject: CHEBI:88316

subject_name: Nefopam

object_name: Post-Operative Pain


subject: CHEBI:88316

object_name: opioid use


subject: CHEBI:6128

subject_name: Ketoprofen


subject: CHEBI:6128


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:46195


subject: UMLS:C1616840

subject_name: Injection, ziconotide, 1 microgram administered

object_name: Pain, Intractable


subject: UMLS:C5203427

subject_name: Ziconotide Liquid Injection


subject: PUBCHEM.COMPOUND:16135415

subject_name: Ziconotide


subject: CHEBI:4445

subject_name: Desflurane

object_name: no feeling or sensation of skin


subject: CHEBI:4445

object_name: Sensory Loss


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: HMDB:HMDB0256702

subject_name: Porfimer Sodium

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: HMDB:HMDB0256702

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: HMDB:HMDB0256702

object_name: gallbladder cancer


subject: HMDB:HMDB0256702

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: HMDB:HMDB0256702

object_name: Stage III Gallbladder Cancer AJCC v8


subject: HMDB:HMDB0256702

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: HMDB:HMDB0256702

object_name: gallbladder carcinoma


subject: HMDB:HMDB0256702

object_name: liver cancer


subject: HMDB:HMDB0256702

object_name: liver neoplasm


subject: HMDB:HMDB0256702

object_name: Adult Liver Carcinoma


subject: HMDB:HMDB0256702

object_name: liver carcinoma


subject: HMDB:HMDB0256702

object_name: pancreatic neoplasm


subject: HMDB:HMDB0256702

object_name: exocrine pancreatic carcinoma


subject: HMDB:HMDB0256702

object_name: malignant pancreatic neoplasm


subject: HMDB:HMDB0256702

object_name: extrahepatic bile duct carcinoma


subject: HMDB:HMDB0256702

object_name: malignant tumor of extrahepatic bile duct


subject: UNII:Y3834SIK5F

subject_name: PORFIMER SODIUM


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UMLS:C3854325

subject_name: Janus kinase inhibitor


subject: UMLS:C3854326

subject_name: Janus Kinase Inhibitor [EPC]


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:64103

subject_name: sodium butyrate

object_name: shigellosis


subject: UMLS:C0142812

subject_name: Sodium Butyrate


subject: CHEBI:30772

subject_name: Butyric Acid


subject: CHEBI:68575

subject_name: Indacaterol

object_name: chronic obstructive pulmonary disease


subject: CHEBI:31355

subject_name: Carboplatin

object_name: non-small cell lung carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UMLS:C5439906


subject: DRUGBANK:DB16438


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Transient disorder of initiating or maintaining sleep


subject: CHEBI:42797

object_name: Transient Insomnia


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: anemia


subject: PUBCHEM.COMPOUND:92043599

object_name: Anemia, CTCAE


subject: PUBCHEM.COMPOUND:92043599

object_name: rheumatoid arthritis


subject: UMLS:C3641122

object_name: Locally Advanced Rectal Carcinoma


subject: UMLS:C2346820


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Post-Operative Pain


subject: CHEBI:41879

object_name: Unstable keratoconus


subject: CHEBI:2639

subject_name: Amiloride

object_name: coronary microvascular disorder


subject: CHEBI:2639

object_name: hypertension


subject: CHEBI:2639

object_name: Hypertension, CTCAE


subject: CHEBI:5778

subject_name: Hydrochlorothiazide


subject: CHEBI:5778


subject: CHEBI:5778


subject: CHEBI:4708

subject_name: Doxazosin


subject: CHEBI:4708


subject: CHEBI:4708


subject: CHEBI:135930

subject_name: Lercanidipine


subject: CHEBI:135930


subject: CHEBI:135930


subject: CHEBI:7009

subject_name: Moxonidine


subject: CHEBI:7009


subject: CHEBI:7009


subject: CHEBI:31905

subject_name: Nicorandil


subject: CHEBI:31905


subject: CHEBI:31905


subject: CHEBI:8214

subject_name: Pindolol


subject: CHEBI:8214


subject: CHEBI:8214


subject: CHEBI:9927

subject_name: Valsartan


subject: CHEBI:9927


subject: CHEBI:9927


subject: CHEBI:82677

subject_name: ridaforolimus

object_name: adult liposarcoma


subject: CHEBI:82677

object_name: liposarcoma


subject: CHEBI:82677

object_name: pediatric liposarcoma


subject: CHEBI:82677

object_name: pediatric osteosarcoma


subject: CHEBI:82677

object_name: Osteosarcoma


subject: CHEBI:82677

object_name: leiomyosarcoma


subject: CHEBI:82677

object_name: Childhood Leiomyosarcoma


subject: CHEBI:82677

object_name: Adult Leiomyosarcoma


subject: CHEBI:82677

object_name: sarcoma


subject: CHEBI:82677

object_name: soft tissue sarcoma


subject: CHEBI:82677

object_name: Embolism, Tumor


subject: CHEBI:82677

object_name: Neoplasm Metastasis


subject: CHEBI:82677

object_name: Metastatic Lesion


subject: CHEBI:42941

object_name: liver carcinoma


subject: CHEBI:138655


subject: PR:000015485

subject_name: spermatogenesis-associated protein 2


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: diabetic macular edema


subject: CHEBI:47898

subject_name: Epirubicin

object_name: malignant soft tissue neoplasm


subject: CHEBI:47898


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:31348

subject_name: Capecitabine

object_name: neuroendocrine neoplasm


subject: CHEBI:31348

object_name: Neuroendocrine tumor grade 2


subject: CHEBI:31348

object_name: atypical carcinoid tumor


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: UNII:56588OP40D

subject_name: interferon alfacon-1

object_name: influenza


subject: UMLS:C0164613

subject_name: Infergen


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Post-Operative Pain


subject: CHEBI:3757

subject_name: Clonidine


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:4875

subject_name: Etanercept

object_name: psoriasis


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: CHEBI:157844

subject_name: Glu-Arg

object_name: Advanced cancer


subject: CHEBI:33379

subject_name: erbium


subject: UMLS:C5441529

subject_name: Estrogen Receptor Family, human


subject: PR:000007204

subject_name: estrogen receptor


subject: MESH:D002214

subject_name: Capsules


subject: CHEBI:50659

subject_name: Dronedarone

object_name: atrial fibrillation


subject: CHEBI:50659

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:50659

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:87681

subject_name: Ranolazine


subject: CHEBI:87681


subject: CHEBI:87681


subject: CHEBI:40009

subject_name: Cycloserine

object_name: social phobia


subject: CHEBI:15365

subject_name: Aspirin

object_name: pelvic pain on the left


subject: CHEBI:15365

object_name: pelvic pain occurs with urination


subject: CHEBI:15365

object_name: pelvic pain occurs with bowel movement


subject: CHEBI:15365

object_name: pelvic pain decreasing in severity


subject: CHEBI:15365

object_name: Pelvic pain female


subject: CHEBI:15365

object_name: pelvic pain increasing in severity


subject: CHEBI:15365

object_name: male pelvic pain


subject: CHEBI:15365

object_name: pelvic pain to the rear


subject: CHEBI:15365

object_name: pelvic pain on the right


subject: CHEBI:15365

object_name: pelvic pain decreasing in frequency


subject: CHEBI:15365

object_name: Pelvic pain


subject: CHEBI:15365

object_name: Pelvic Pain, CTCAE 5.0


subject: CHEBI:15365

object_name: pelvic pain causes awakening at night


subject: CHEBI:15365

object_name: pelvic pain increasing in frequency


subject: CHEBI:15365

object_name: pelvic pain occurs with intercourse


subject: CHEBI:15365

object_name: pelvic pain in front


subject: CHEBI:31355

subject_name: Carboplatin

object_name: anal squamous cell carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Stomach cancer


subject: UNII:5S371K6132

object_name: gastric cancer


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: diabetic macular edema


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEMBL.COMPOUND:CHEMBL5314348

subject_name: BIVALIRUDIN

object_name: Extracorporeal membrane oxygenation complication


subject: UMLS:C1314413

subject_name: INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


subject: CHEBI:59173

subject_name: Bivalirudin


subject: UMLS:C0592163

subject_name: Tegretol XR

object_name: alpha 1-antitrypsin deficiency


subject: UMLS:C0592163

object_name: liver cirrhosis


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: graft versus host disease


subject: CHEBI:2038

subject_name: Azacitidine


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: metastatic colorectal cancer


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:31348

subject_name: Capecitabine


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:6801

object_name: hepatic encephalopathy


subject: CHEBI:6503

subject_name: LISINOPRIL

object_name: gastroparesis


subject: CHEBI:6503

object_name: Gastroparesis, CTCAE


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:43755


subject: PUBCHEM.COMPOUND:3033637

subject_name: nizatidine


subject: PUBCHEM.COMPOUND:3033637


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:2516

subject_name: Cafestol

object_name: type 2 diabetes mellitus


subject: CHEBI:6801

object_name: cystic fibrosis


subject: CHEBI:6801

object_name: cystic fibrosis-related diabetes


subject: CHEBI:9907

subject_name: ursodiol

object_name: cholelithiasis


subject: UNII:L1F3R18W77

subject_name: Asciminib

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: non-small cell lung carcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: anterior uveitis


subject: CHEBI:151315

subject_name: Heparin

object_name: cancer


subject: CHEBI:151315

object_name: neoplasm


subject: CHEBI:151315

object_name: Blood Clot


subject: CHEBI:151315

object_name: thrombosis


subject: CHEBI:151315

object_name: Thrombosis of blood vessel


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:IKE1P4X57J

subject_name: Aggrastat

object_name: Acute Ischemic Stroke


subject: UNII:IKE1P4X57J

object_name: Acute Stroke


subject: UNII:IKE1P4X57J

object_name: Acute Stroke Related to COVID-19


subject: UNII:IKE1P4X57J

object_name: stroke disorder


subject: UNII:IKE1P4X57J

object_name: cerebral infarction


subject: UNII:IKE1P4X57J

object_name: cerebrovascular disorder


subject: CHEBI:9605

subject_name: Tirofiban


subject: CHEBI:9605


subject: CHEBI:9605


subject: CHEBI:9605


subject: CHEBI:9605


subject: CHEBI:9605


subject: PUBCHEM.COMPOUND:60918

subject_name: tegaserod

object_name: dyspepsia


subject: PUBCHEM.COMPOUND:60918

object_name: Dyspepsia, CTCAE


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Unknown Primary Tumors


subject: CHEBI:175901

subject_name: Gemcitabine


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:228346

object_name: schizophrenia


subject: UMLS:C5700219

subject_name: Therapeutic allogeneic lymphocytes

object_name: Infection


subject: UMLS:C5700219

object_name: infectious disease


subject: UMLS:C5700219

object_name: Adverse Event Associated with Infection


subject: UMLS:C5565788

subject_name: Elpida

object_name: HIV infection


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: Head and neck cancer metastatic


subject: CHEBI:63584

object_name: Recurrent Malignant Head and Neck Neoplasm


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stomach cancer


subject: PUBCHEM.COMPOUND:2767

object_name: gastric cancer


subject: PUBCHEM.COMPOUND:2767

object_name: stage IV esophageal cancer


subject: PUBCHEM.COMPOUND:2767

object_name: gastroesophageal cancer


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174